ACADIA PHARMACEUTICALS INC (ACAD) Form 8-K — May 29, 2026
$ACADForm 8-KItems 5.02, 5.07, 9.01Filed May 29, 2026, 8:00 AM ET0001193125-26-248242Original filing
Acadia Pharmaceuticals Inc. held its 2026 Annual Meeting of Stockholders on May 29, 2026, where stockholders elected three Class I directors: James M. Daly, Edmund P. Harrigan, M.D., and Adora Ndu, Pharm.D., J.D.
Key figures
- Iso limit
- 61679010
- Votes for auditor
- 157409378
- Shares added to plan
- 5209670
- Votes for say on pay
- 148265173
- Votes against auditor
- 3319736
- Votes for equity plan
- 147258860
- Votes for director ndu
- 134540552
- Votes for director daly
- 146927745
- Votes against say on pay
- 1911358
- Votes against equity plan
- 3096136
- Votes for director harrigan
- 128460130
- Total plan shares post amendment
- 18885167
Price after filing
1 day: +0.1%7 days: +0.4%30 days: +9.7%
Close on the filing date to close N calendar days later (from $21.63). Historical, not a forecast.
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.